163 related articles for article (PubMed ID: 8044389)
1. Thromboxane synthetase inhibition and thromboxane receptor blockade preserve pulmonary and circulatory function in a porcine burn sepsis model.
Iglesias G; Zeigler ST; Lentz CW; Traber DL; Herndon DN
J Am Coll Surg; 1994 Aug; 179(2):187-92. PubMed ID: 8044389
[TBL] [Abstract][Full Text] [Related]
2. Effects of thromboxane synthetase inhibition on postburn mesenteric vascular resistance and the rate of bacterial translocation in a chronic porcine model.
Tokyay R; Loick HM; Traber DL; Heggers JP; Herndon DN
Surg Gynecol Obstet; 1992 Feb; 174(2):125-32. PubMed ID: 1734570
[TBL] [Abstract][Full Text] [Related]
3. Effects of ketanserin on pulmonary hemodynamics, lung mechanics, and gas exchange in endotoxemic pigs.
Olson NC; Grizzle MK; Anderson DL
Am J Vet Res; 1986 Oct; 47(10):2193-6. PubMed ID: 3777645
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of BM-573, a novel TXA2 synthase inhibitor and receptor antagonist, in a porcine model of myocardial ischemia-reperfusion.
Kolh P; Rolin S; Tchana-Sato V; Pétein M; Ghuysen A; Lambermont B; Hanson J; Magis D; Segers P; Masereel B; D'Orio V; Dogne JM
Prostaglandins Other Lipid Mediat; 2006 Mar; 79(1-2):53-73. PubMed ID: 16516810
[TBL] [Abstract][Full Text] [Related]
5. Effect of BM-573 [N-terbutyl-N'-[2-(4'-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, in a porcine model of acute pulmonary embolism.
Ghuysen A; Lambermont B; Dogné JM; Kolh P; Tchana-Sato V; Morimont P; Magis D; Hanson J; Segers P; D'Orio V
J Pharmacol Exp Ther; 2004 Sep; 310(3):964-72. PubMed ID: 15121765
[TBL] [Abstract][Full Text] [Related]
6. Gut failure and translocation following burn and sepsis.
Baron P; Traber LD; Traber DL; Nguyen T; Hollyoak M; Heggers JP; Herndon DN
J Surg Res; 1994 Jul; 57(1):197-204. PubMed ID: 8041138
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist.
Hanson J; Rolin S; Reynaud D; Qiao N; Kelley LP; Reid HM; Valentin F; Tippins J; Kinsella BT; Masereel B; Pace-Asciak C; Pirotte B; Dogné JM
J Pharmacol Exp Ther; 2005 Apr; 313(1):293-301. PubMed ID: 15626721
[TBL] [Abstract][Full Text] [Related]
8. Thromboxane receptor blockade does not attenuate pulmonary pressor response in porcine single lung transplantation.
Kukkonen S; Heikkilä L; Verkkala K; Mattila S; Toivonen H
J Heart Lung Transplant; 1996 Apr; 15(4):409-14. PubMed ID: 8732601
[TBL] [Abstract][Full Text] [Related]
9. Preliminary clinical studies with thromboxane synthase inhibitors and thromboxane receptor blockers. A review.
Fiddler GI; Lumley P
Circulation; 1990 Jan; 81(1 Suppl):I69-78; discussion I79-80. PubMed ID: 2136820
[TBL] [Abstract][Full Text] [Related]
10. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C
J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831
[TBL] [Abstract][Full Text] [Related]
11. Thromboxane and prostacyclin in acute lung injury caused by venous air emboli in unanesthetized sheep.
Bonsignore MR; Rice TR; Dodek PM; Staub NC
Microcirc Endothelium Lymphatics; 1986; 3(2):187-212. PubMed ID: 3295507
[TBL] [Abstract][Full Text] [Related]
12. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs.
Murayama K; Kasai H; Adachi T; Utsunomiya O; Ouchi H
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):344-50. PubMed ID: 6339650
[TBL] [Abstract][Full Text] [Related]
14. Effect of a novel thromboxane A2 inhibitor on right ventricular-arterial coupling in endotoxic shock.
Lambermont B; Kolh P; Ghuysen A; Segers P; Dogné JM; Tchana-Sato V; Morimont P; Benoit P; Gérard P; Masereel B; D'Orio V
Shock; 2004 Jan; 21(1):45-51. PubMed ID: 14676683
[TBL] [Abstract][Full Text] [Related]
15. Opposite effects of prostacyclin on hepatic blood flow and oxygen consumption after burn and sepsis.
Tadros T; Traber DL; Herndon DN
Ann Surg; 2004 Jan; 239(1):67-74. PubMed ID: 14685102
[TBL] [Abstract][Full Text] [Related]
16. BM-573, a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, prevents pig myocardial infarction induced by coronary thrombosis.
Rolin S; Petein M; Tchana-Sato V; Dogne JM; Benoit P; Lambermont B; Ghuysen A; Kolh P; Masereel B
J Pharmacol Exp Ther; 2003 Jul; 306(1):59-65. PubMed ID: 12721335
[TBL] [Abstract][Full Text] [Related]
17. Is endotoxin responsible for the cardiopulmonary lesions seen during acute burn wound sepsis?
Traber DL; Adair TH; Adams T; Henriksen N; Traber LD
Adv Shock Res; 1982; 7():91-100. PubMed ID: 6753541
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic variables and plasma levels of PGI2, TXA2 and IL-6 in a porcine model of recurrent endotoxemia.
Klosterhalfen B; Hörstmann-Jungemann K; Vogel P; Dufhues G; Simon B; Kalff G; Kirkpatrick CJ; Mittermayer C; Heinrich PC
Circ Shock; 1991 Dec; 35(4):237-44. PubMed ID: 1777960
[TBL] [Abstract][Full Text] [Related]
19. [Effect of thromboxane A2 synthetase inhibitor (OKY-046) on leukotriene C4-induced airway hyperresponsiveness in guinea pigs].
Tsukagoshi H; Yodonawa S; Kurosawa M
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jun; 31(6):707-11. PubMed ID: 8345703
[TBL] [Abstract][Full Text] [Related]
20. Endotoxin versus bacteremia: a comparison focusing on clinical relevance.
Booke M; Lingnau W; Hinder F; Traber LD; Traber DL
Prog Clin Biol Res; 1995; 392():393-403. PubMed ID: 8524947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
